Open AccessThis article is
- freely available
Chemokine Receptors in Epithelial Ovarian Cancer
Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 S Wood Street, PHARM335, Chicago, IL 60612, USA
* Author to whom correspondence should be addressed.
Received: 2 December 2013; in revised form: 17 December 2013 / Accepted: 19 December 2013 / Published: 31 December 2013
Abstract: Ovarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival, and it is characterized by the presence of vast incurable peritoneal metastasis. Studies of the role of chemokine receptors, a family of proteins belonging to the group of G protein-coupled receptors, in ovarian carcinoma strongly placed this family of membrane receptors as major regulators of progression of this malignancy. In this review, we will discuss the roles that chemokine-receptor interactions play to support angiogenesis, cell proliferation, migration, adhesion, invasion, metastasis, and immune evasion in progression of ovarian carcinoma. Data regarding the role that the chemokine receptors play in the disease progression accumulated insofar strongly suggest that this family of proteins could be good therapeutic targets against ovarian carcinoma.
Keywords: ovarian carcinoma; chemokine receptor; metastasis; angiogenesis; invasion; migration; proliferation; immune response
Citations to this Article
Cite This Article
MDPI and ACS Style
Muralidhar, G.G.; Barbolina, M.V. Chemokine Receptors in Epithelial Ovarian Cancer. Int. J. Mol. Sci. 2014, 15, 361-376.
Muralidhar GG, Barbolina MV. Chemokine Receptors in Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 2014; 15(1):361-376.
Muralidhar, Goda G.; Barbolina, Maria V. 2014. "Chemokine Receptors in Epithelial Ovarian Cancer." Int. J. Mol. Sci. 15, no. 1: 361-376.